iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC) Trading Down 0.4% – Should You Sell?

iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDCGet Free Report)’s stock price fell 0.4% during trading on Wednesday . The company traded as low as $36.49 and last traded at $36.57. 53,753 shares traded hands during mid-day trading, an increase of 127% from the average daily volume of 23,665 shares. The stock had previously closed at $36.70.

iShares LifePath Target Date 2035 ETF Trading Down 0.4%

The firm’s 50-day moving average price is $36.22 and its 200-day moving average price is $35.14. The stock has a market capitalization of $102.40 million, a PE ratio of 20.04 and a beta of 0.65.

Institutional Investors Weigh In On iShares LifePath Target Date 2035 ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC bought a new stake in shares of iShares LifePath Target Date 2035 ETF in the 1st quarter valued at approximately $345,000. Creative Planning purchased a new position in shares of iShares LifePath Target Date 2035 ETF in the 3rd quarter worth approximately $203,000. Finally, Kestra Advisory Services LLC bought a new position in shares of iShares LifePath Target Date 2035 ETF during the 4th quarter valued at approximately $102,000.

iShares LifePath Target Date 2035 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2035 ETF USD (ITDC) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2035 ITDC was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2035 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2035 ETF and related companies with MarketBeat.com's FREE daily email newsletter.